compugen
Gilead and Compugen enter exclusive license agreement for immunotherapy programme
December 20, 2023Research and Development Gilead Sciences, Immunology, License Agreement, compugen, immunology
Gilead Sciences and Compugen have announced that they have entered an exclusive license agreement for Compugen’s potential first in class, …
AZ’s MedImmune signs $200m immuno-oncology partnership with Compugen
April 3, 2018Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, MedImmune, compugen, immunotherapy, oncology, pharma
AstraZeneca’s biologic R&D unit MedImmune is set to enter a partnership with Israeli drug firm Compugen to develop bi-specific and …
Bayer signs cancer vaccine research deal
August 6, 2013Research and Development, Sales and Marketing Bayer, Vaccine, compugen
Bayer has entered into a new collaboration with Compugen to develop cancer vaccines aimed at helping the body fight off …
